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Prescription dose was 36-75Gy in 3-6 fractions. SBRT was 
delivered using the volumetric modulated arc therapy 
technique with flattening filter free photon beams. The 
primary end points of this study were in–field local control 
(LC) and toxicity. Secondary end points were overall survival 
(OS) and progression free survival (PFS).  
Results: 43 patients with 63 HCC lesions were irradiated. All 
patients had Child-Turcotte-Pugh class A or B disease. Median 
follow-up was 8 months (range 3-43 months). Actuarial LC at 
1 and 2years was 86% and 64%. An Equivalent Dose >100Gy 
and GTV size were significant prognostic factors for LC in 
univariate analysis (p<0.001 and p<0.02). Median OS was 18 
months. Actuarial OS at 1 and 2 years was 78% and 45%, 
respectively. Univariate analysis showed that OS is correlated 
with LC (p<0.04), BED>100 (p<0.05) and Cumulative GTV<5cm 
(p<0.04). Median PFS was 8 months, with a 1-year PFS rate of 
41%. Grade ≥3 toxicity was observed in 7 patients (16%). No 
classic RILD was observed. 
Conclusions: Our study show that SBRT is a safe and effective 
treatment for selected patients with inoperable HCC. Local 
control rates and toxicity profile were encouraging.  
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Purpose/Objective: Chemoradiotherapy (CRT) followed by 
complete surgical removal is regarded as standard of care for 
locally advanced rectal cancer (LARC). To further improve 
clinical outcome therapeutic approaches may incorporate 
additional agents to the standard fluorouracil (FU)-based 
CRT. Intensified preoperative treatment with systemic 
neoadjuvant chemotherapy (NACT) before conventional long-
course CRT has shown promising long-term outcome and 
acceptable safety profiles. However, at present, it remains 
challenging to reliably identify good and poor responders at 
an early stage in order to achieve more individualized, 
effective and less toxic treatment of these patients. In this 
study, the purpose was to investigate if magnetic resonance 
imaging (MRI)-assessed tumor volumetry predicts histologic 
tumor response to NACT and subsequent CRT in LARC. 
Materials and Methods: The treatment in this experimental 
study consisted of two cycles of bolus 5-FU and oxaliplatin 
followed by long-course radiotherapy delivered 
concomitantly with capecitabine and oxaliplatin, before 
radical surgery. Complete MRI data sets and tumor 
histopathology from 69 prospectively enrolled patients were 
analyzed. Whole-tumor volumes were contoured in T2-
weighted MR images obtained pretreatment (VPRE), after 
NACT (VNACT), and after the full course of NACT followed by 
CRT (VCRT). VPRE, VNACT, and tumor volume changes relative to 
VPRE, DVNACT and DVCRT, were calculated and correlated to 
histologic tumor regression grade (TRG). 
Results: In total, 61% of good histologic responders (TRG 1-2) 
to NACT followed by CRT were correctly predicted by small 
pretreatment tumor volumes (VPRE < 10.5 cm3), large volume 
regressions after NACT (DVNACT > -78.2%), or small tumor 
volumes after NACT (VNACT < 3.3 cm3). Small pretreatment 
volume and large volume regression after NACT identified 
different patients; only six patients had both small 
pretreatment volume and large volume regression. Small 
tumor volume after NACT identified the majority of good 
responders (n = 27), with a sensitivity of 55.1% and a 
specificity of 100% (area under curve = 0.84), although the 
combined use of all three volumetric measurements 
identified the most. The volume regression after completed 
NACT and CRT (VCRT) was not significantly different between 
good and poor responders (TRG 1-2 versus TRG 3-5).  
Conclusions: MRI-assessed small tumor volumes following 
NACT, before the commencement of CRT, predicted good 
histologic tumor response (TRG1-2) to the completed course 
of NACT and CRT with high accuracy. Further, the combined 
use of tumor volume measurements before, during, and after 
NACT identified most good responders. MR volumetry may be 
used to improve individualized, multimodal treatment of 
LARC. 
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Purpose/Objective: To evaluate the role of 3T 
multiparametric MRI (3TmMRI) without endo-rectal coil (ERC) 
in the detection of radiographic local recurrences (rLR) in a 
contemporary cohort of patients with prostate cancer treated 
at our hospital and who presented a biochemical recurrence 
after PR with low PSA levels and to identify clinical 
parameters associated with the findings of the 3TmMRI.  
Materials and Methods: Between 2009 and 2013, 57 patients 
with biochemical recurrence after RP of a PC and considered 
for salvage radiation therapy (SRT) were included. 3TmMRI 
with T2-weighted imaging (T2WI), diffusion weighted imaging 
(DWI) and dynamic contrast-enhanced images (DCE) without 
ERC was carried out in all the patients prior to treatment. 
Given that there are no validated criteria, a points system 
was established to define the findings of the 3TmMRI, 0 being 
(normal; no abnormality was observed in the MRI sequences: 
T2WI, DWI or DCE), 1 being (doubtful; an abnormality was 
detected in one of the MRI sequences, with no correlation in 
the rest of the sequences) and 2 being (abnormal; 
abnormality detected in all or in two of the sequences). The 
local relapse was defined as 2. To analyze the relationship 
